Dolstra, Harry

Induction of myelodysplasia by myeloid-derived suppressor cells

Chen, X., Eksioglu, E. A., Zhou, J., Zhang, L., Djeu, J., Fortenbery, N., Epling-Burnette, P., Van Bijnen, S., Dolstra, H., Cannon, J., et al. (2013) · Journal of Clinical Investigation

Immune cells in cancerAcute Myeloid Leukemia Research

Cited by 316

Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells

Wimmers, F., Subedi, N., van Buuringen, N., Heister, D., Vivié, J., Beeren-Reinieren, I., Woestenenk, R., Dolstra, H., Piruska, A., Jacobs, J. F. M., et al. (2018) · Nature Communications

interferon and immune responsesImmune Response and Inflammation

Cited by 150

What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings

ten Ham, R. M. T., Hövels, A. M., Hoekman, J., Frederix, G. W. J., Leufkens, H. G. M., Klungel, O. H., Jedema, I., Veld, S. A. J., Nikolic, T., Van Pel, M., et al. (2020) · Cytotherapy

Pharmaceutical Economics and PolicyCAR-T cell therapy research

Cited by 73

Expression of C‐IAP1, C‐IAP2 and SURVIVIN discriminates different types of lymphoid malignancies

de Graaf, A. O., Han van Krieken, J., Tönnissen, E., Wissink, W., van de Locht, L., Overes, I., Dolstra, H., de Witte, T., van der Reijden, B. A., & Jansen, J. H. (2005) · British Journal of Haematology

Cell death mechanisms and regulationLymphoma Diagnosis and Treatment

Cited by 42